Vista Pharmaceuticals Limited (BOM: 524711)

Vista Pharmaceuticals Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2024	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Cash & Equivalents	26.38	0.94	2.04	0.72	1.4	2.25
Cash & Short-Term Investments	26.38	0.94	2.04	0.72	1.4	2.25
Cash Growth	989.88%	-53.70%	183.59%	-48.68%	-37.79%	-74.05%
Accounts Receivable	120.58	142.81	112.51	104.64	21.69	102.8
Other Receivables	-	8.71	11.48	9.83	9.55	9.98
Receivables	120.58	151.58	124.77	137.38	54.15	112.78
Inventory	98.31	67.86	76.77	93.28	96.82	96.82
Prepaid Expenses	-	0.04	-	-	-	-
Other Current Assets	40.41	13.53	33.93	4.25	-	0
Total Current Assets	285.67	233.96	237.51	235.63	152.37	211.85
Property, Plant & Equipment	194.68	195.84	195.14	188.61	194.62	198.9
Long-Term Investments	0.25	0.21	0.17	0.31	0.41	0.17
Other Intangible Assets	95.53	95.53	95.53	95.53	-	-
Long-Term Deferred Tax Assets	39.02	33.09	26.44	34.82	-17.53	3.8
Long-Term Deferred Charges	-	-	-	-	95.53	95.53
Other Long-Term Assets	21.25	21.16	5.51	1	83.14	0.96
Total Assets	636.4	579.79	560.29	555.9	508.54	511.22
Accounts Payable	68.01	74.05	78.03	53.67	51.05	51.62
Accrued Expenses	-	12.07	3.58	10.13	6.58	5.72
Short-Term Debt	-	19.18	19.89	31.84	20.19	91.29
Current Portion of Long-Term Debt	34.93	31.14	27.91	19.42	-	8.32
Other Current Liabilities	16.73	8.48	11.42	11.35	14.64	2.28
Total Current Liabilities	119.67	144.92	140.82	126.39	92.46	159.22
Long-Term Debt	33.56	29.33	51.79	74.26	86.93	55.07
Other Long-Term Liabilities	-	-	-0	-	0	-0
Total Liabilities	154.14	175.17	193.22	201.37	180.08	214.8
Common Stock	123.1	94.33	75.11	73.59	73.59	60.73
Additional Paid-In Capital	-	358.87	282.01	275.9	275.9	198.76
Retained Earnings	-	-104.71	-59.59	-2.97	-29.14	28.82
Comprehensive Income & Other	359.15	56.13	69.55	8.01	8.11	8.11
Shareholders' Equity	482.26	404.62	367.08	354.53	328.46	296.42
Total Liabilities & Equity	636.4	579.79	560.29	555.9	508.54	511.22
Total Debt	68.49	79.65	99.59	125.51	107.12	154.67
Net Cash (Debt)	-42.11	-78.7	-97.55	-124.79	-105.72	-152.42
Net Cash Per Share	-0.80	-1.80	-2.65	-3.39	-3.05	-5.02
Filing Date Shares Outstanding	60.86	47.16	61.55	36.79	36.79	30.37
Total Common Shares Outstanding	60.86	47.16	37.56	36.79	36.79	30.37
Working Capital	166.01	89.03	96.68	109.23	59.91	52.63
Book Value Per Share	7.92	8.58	9.77	9.64	8.93	9.76
Tangible Book Value	386.73	309.09	271.55	259	328.46	296.42
Tangible Book Value Per Share	6.35	6.55	7.23	7.04	8.93	9.76
Land	-	0.99	0.99	0.99	0.99	0.99
Buildings	-	65.42	65.42	65.42	65.42	65.42
Machinery	-	108.67	105.67	95.43	95.28	95.29
Construction In Progress	-	98.19	93.29	90.83	90.81	87.82

Source: S&P Capital IQ. Standard template. Financial Sources.